Transplant drugs may help defeat HIV
Drugs that are currently given to prevent organ rejection in patients who have received a transplant may offer a new approach to curing HIV, say researchers.
View ArticleSanten announces Phase III results of sirolimus intravitreal injections in...
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. (Osaka, Japan), today announced that SAKURA (Study Assessing double‐masKed Uveitis...
View ArticleDocs who treat patients with severe LAM face agonizing treatment decision
Doctors who treat patients with a severe and progressive respiratory disease called lymphangioleiomyomatosis (LAM) can face an agonizing treatment decision.
View ArticleJanssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for...
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A...
View ArticleMicell Technologies presents DESSOLVE I and II trial data at EuroPCR conference
Micell Technologies, Inc. today announced that long-term clinical outcomes from its DESSOLVE I and II clinical trials were presented at the EuroPCR conference in Paris, France this week.
View ArticleSTENTYS signs agreement to acquire assets of Cappella Peel Away
STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced the signing of the...
View ArticleBone marrow transplantation shows promising results among patients with...
Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of...
View ArticleMayo Clinic heart transplant surgeons present findings from three clinical...
Heart transplant surgeons from Mayo Clinic are presenting findings from three recent clinical studies involving heart transplant patients. The presentations took place during the 2015 International...
View ArticleSteroid-refractory chronic GVHD trial results ‘overestimate’ treatment efficacy
Trial results for patients with steroid-refractory chronic graft versus host have overestimated the efficacies of treatments, suggests a meta-analysis published in The Lancet Haematology.
View ArticlePRESTIGE study suggests novel target to prevent stent thrombosis
Recruitment of leukocytes is a hallmark of stent thrombosis, according to results from the PRESTIGE study presented today at ESC Congress and published in European Heart Journal. The findings suggest...
View ArticleFDA awards research grants to boost product development for patients with...
The U.S. Food and Drug Administration today announced it has awarded 18 new research grants totaling more than $19 million to boost the development of products for patients with rare diseases, which...
View ArticlePatients with treatment-resistant autoimmune blood conditions may benefit...
The immunosuppressant sirolimus is an effective and safe steroid-sparing therapy for children and young adults with highly treatment-resistant autoimmune blood conditions, according to a study...
View ArticleSirolimus chemoprevention supported in organ transplant recipients
In solid-organ transplant recipients diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.
View ArticleNovartis announces FDA approval of Afinitor for progressive, nonfunctional...
Novartis today announced that the United States Food and Drug Administration approved Afinitor (everolimus) tablets for the treatment of adult patients with progressive, well-differentiated,...
View ArticleRare disease day focuses on new approach to finding treatment
2,200 babies will be born in the UK on 29th February, of which 30 will die of a rare disease before they are five years old.
View ArticlePCI with polymer-free BA9 drug-coated stent better than bare metal stent in...
Patients with acute coronary syndromes (ACS) who are at high risk for bleeding have significantly lower rates of target lesion revascularisation and fewer adverse events after undergoing percutaneous...
View ArticleATS releases new clinical practice guidelines for diagnosis, management of LAM
The American Thoracic Society and the Japanese Respiratory Society have published new clinical practice guidelines for the diagnosis and management of lymphangioleiomyomatosis (LAM), a rare lung...
View ArticleTCT 2016 features first report investigations on novel bioresorbable stents
The 28th annual Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation featured a number of first report investigations on novel...
View ArticleStudy of new polymer-free DFS indicates non-inferior in-stent late lumen loss...
A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late lumen loss at nine-months compared...
View ArticleOrbusNeich launches new Dual Therapy Stent for active vessel healing
OrbusNeich has announced the launch of its latest generation Dual Therapy Stent (DTS), the COMBO Plus.
View Article